|
|
Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas
Eve Maubec
,
Marouane Boubaya
,
Peter Petrow
,
Marie Beylot-Barry
,
Nicole Basset-Seguin
,
et al.
Journal articles
hal-03368957v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prevalence, distribution and predictive value of XPO1 mutation in a real‐life chronic lymphocytic leukaemia cohort
Giulia Tueur
,
Gregory Lazarian
,
Virginie Eclache
,
Carole Fleury
,
Rémi Letestu
,
et al.
Journal articles
hal-03942496v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
TP53, XPO1 and ATM Mutations Exclusive Distribution in the Adverse Prognosis Chronic Lymphocytic Leukemia (CLL) Group
Giulia Tueur
,
Virginie Eclache
,
Grégory Lazarian
,
Carole Fleury
,
Rémi Letestu
,
et al.
Conference poster
inserm-03950185v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Nurselike cells sequester B cells in disorganized lymph nodes in chronic lymphocytic leukemia via alternative production of CCL21
Rim Zaaboub
,
Lene Vimeux
,
Vincent Contremoulins
,
Florence Cymbalista
,
Vincent Lévy
,
et al.
Journal articles
hal-03869266v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Obesity survival paradox in cancer patients: Results from the Physical Frailty in older adult cancer patients (PF-EC) study
Frederic Pamoukdjian
,
Thomas Aparicio
,
Florence Canoui-Poitrine
,
Boris Duchemann
,
Vincent Lévy
,
et al.
Journal articles
hal-02981722v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|